111 related articles for article (PubMed ID: 3841069)
1. Prenatal exposure of rats to antidepressants enhances agonist affinity of brain dopamine receptors and dopamine-mediated behaviour.
De Ceballos ML; Benedi A; De Felipe C; Del Rio J
Eur J Pharmacol; 1985 Oct; 116(3):257-62. PubMed ID: 3841069
[TBL] [Abstract][Full Text] [Related]
2. Repeated administration of antidepressants enhances agonist affinity for mesolimbic D2-receptors.
Klimek V; Maj J
J Pharm Pharmacol; 1989 Aug; 41(8):555-8. PubMed ID: 2571700
[TBL] [Abstract][Full Text] [Related]
3. Prenatal exposure of rats to antidepressant drugs down-regulates beta-adrenoceptors and 5-HT2 receptors in cerebral cortex. Lack of correlation between 5-HT2 receptors and serotonin-mediated behaviour.
De Ceballos ML; Benedi A; Urdin C; Del Rio J
Neuropharmacology; 1985 Oct; 24(10):947-52. PubMed ID: 2999633
[TBL] [Abstract][Full Text] [Related]
4. Evidence of dopamine involvement in the effect of repeated treatment with various antidepressants in the behavioural 'despair' test in rats.
Borsini F; Pulvirenti L; Samanin R
Eur J Pharmacol; 1985 Apr; 110(2):253-6. PubMed ID: 3987815
[TBL] [Abstract][Full Text] [Related]
5. Behavioural and neurochemical changes in offspring of rats exposed to methyl mercury during gestation.
Cuomo V; Ambrosi L; Annau Z; Cagiano R; Brunello N; Racagni G
Neurobehav Toxicol Teratol; 1984; 6(3):249-54. PubMed ID: 6541762
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants.
Martin-Iverson MT; Leclere JF; Fibiger HC
Eur J Pharmacol; 1983 Oct; 94(3-4):193-201. PubMed ID: 6418553
[TBL] [Abstract][Full Text] [Related]
7. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
8. Effect of gestational and neonatal styrene exposure on dopamine receptors.
Zaidi NF; Agrawal AK; Srivastava SP; Seth PK
Neurobehav Toxicol Teratol; 1985; 7(1):23-8. PubMed ID: 4039799
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
[TBL] [Abstract][Full Text] [Related]
10. Behavioural changes in rats after prenatal administration of typical and atypical antidepressants.
Cuomo V; Cortese I; Cagiano R; Renna G; Racagni G
Arch Toxicol Suppl; 1984; 7():504-7. PubMed ID: 6596023
[TBL] [Abstract][Full Text] [Related]
11. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL
Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237
[TBL] [Abstract][Full Text] [Related]
12. Chronic antidepressant drug treatment attenuates motor-suppressant effects of apomorphine without changing [3H]GBR 12935 binding.
Allison K; Paetsch PR; Baker GB; Greenshaw AJ
Eur J Pharmacol; 1993 Nov; 249(2):125-31. PubMed ID: 8287894
[TBL] [Abstract][Full Text] [Related]
13. Prenatal cocaine exposure fails to modify neurobehavioral responses and the striatal dopaminergic system in newborn rats.
Fung YK; Reed JA; Lau YS
Gen Pharmacol; 1989; 20(5):689-93. PubMed ID: 2606336
[TBL] [Abstract][Full Text] [Related]
14. Increased low-affinity 3H-spiroperidol binding to rat cortical membranes after chronic antidepressant treatments.
Antkiewicz-Michaluk L; Rokosz-Pelc A; Vetulani J
Pol J Pharmacol Pharm; 1985; 37(3):317-23. PubMed ID: 4070080
[TBL] [Abstract][Full Text] [Related]
15. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
[TBL] [Abstract][Full Text] [Related]
16. Studies on the participation of the dopaminergic system in the central effects of chronically administered antidepressant drugs.
Kozyrska C; Zebrowska-Lupina I
Pol J Pharmacol Pharm; 1983; 35(2):115-26. PubMed ID: 6684769
[TBL] [Abstract][Full Text] [Related]
17. Effects of prenatal nicotine exposure on rat striatal dopaminergic and nicotinic systems.
Fung YK; Lau YS
Pharmacol Biochem Behav; 1989 May; 33(1):1-6. PubMed ID: 2780768
[TBL] [Abstract][Full Text] [Related]
18. Dopamine and melatonin in the nucleus accumbens may be implicated in the mode of action of antidepressant drugs.
Durlach-Misteli C; Van Ree JM
Eur J Pharmacol; 1992 Jun; 217(1):15-21. PubMed ID: 1397023
[TBL] [Abstract][Full Text] [Related]
19. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
Arnt J
Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
[TBL] [Abstract][Full Text] [Related]
20. Behavioural and biochemical changes following chronic administration of L-dopa to rats.
Pycock C; Dawbarn D; O'Shaughnessy C
Eur J Pharmacol; 1982 Apr; 79(3-4):201-15. PubMed ID: 7201400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
